Tech Company Financing Transactions
AmpliMed Funding Round
Solstice Capital and Valley Ventures participated in a $3.7 million venture round for AmpliMed. This VC investment round closed on 9/30/2009.
Transaction Overview
Company Name
Announced On
9/30/2009
Transaction Type
Venture Equity
Amount
$3,689,000
Round
Undisclosed
Investors
Solstice Capital (Harry George)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1730 E River Rd. 100-A
Tucson, AZ 85718
USA
Tucson, AZ 85718
USA
Phone
Website
Email Address
Not Recorded
Overview
AmpliMed Corporation, a clinical-stage pharmaceutical company founded by world-renowned oncologists, has a lead compound, Amplimexon, in Phase II clinical trials, with early evidence of efficacy and low levels of toxicity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Dorr
Browse more venture capital transactions:
Prev: 9/30/2009: iWatt venture capital transaction
Next: 9/30/2009: SoundHound venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs